|The ZNF622 n/a (Catalog #MBS6012055) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. The ZNF622 (ZNF622, ZPR9, Zinc finger protein 622, Zinc finger-like protein 9) reacts with Mouse and may cross-react with other species as described in the data sheet. MyBioSource\'s ZNF622 can be used in a range of immunoassay formats including, but not limited to, ELISA (EL/EIA), Western Blot (WB).
Suitable for use in Western Blot, ELISA.
Dilution: ELISA: 1:1000
Western Blot: 1:100~500. Researchers should empirically determine the suitability of the ZNF622 n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The ZNF622 n/a product has the following accession number(s) (GI #77735857) (NCBI Accession #NP_001029623.1). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
ZNF622 may behave as an activator of the bound transcription factor, MYBL2, and be involved in embryonic development.
Immunogen: ZNF622 Mab is generated from mouse immunized with ZNF622 recombinant protein. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing ZNF622 are readily searchable from our website. Different antibodies against the same target such as ZNF622 may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.